Media Summary: CNBC's Melissa Lee reports on the latest news. DEK: Data is critical as we continue to fight the pandemic - and genetic research In an exclusive interview with "CBS Mornings" co-host Gayle King,

23andme Ceo Files Proposal To Take Company Private As Stock Craters - Detailed Analysis & Overview

CNBC's Melissa Lee reports on the latest news. DEK: Data is critical as we continue to fight the pandemic - and genetic research In an exclusive interview with "CBS Mornings" co-host Gayle King, In a shocking move, all independent directors at

Photo Gallery

23andMe CEO files proposal to take company private as stock craters
23andMe CEO Set to Take On Sales Slump | DNA Testing: The Promise And The Peril
23andMe Files For Bankruptcy And CEO Anne Wojcicki Exits—Here's What We Know
How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong
23andMe CEO Is Happy to be Done With SPAC Process
23andMe CEO on genetic testing relaunch, protecting privacy
Inside 23andMe CEO Anne Wojcicki's vision for the company: It "will transform health care"
23andMe CEO Wojcicki: We are part of the problem
23andMe CEO Wojcicki on Telehealth, Covid Research
23andMe Board Resigns: CEO's Bold Plan to Go Private Sparks Major Shakeup"
23andMe CEO talks growth, drug development, and the future of health care
23andMe files for Chapter 11 bankruptcy as co-founder and CEO resigns
View Detailed Profile
23andMe CEO files proposal to take company private as stock craters

23andMe CEO files proposal to take company private as stock craters

CNBC's Melissa Lee reports on the latest news.

23andMe CEO Set to Take On Sales Slump | DNA Testing: The Promise And The Peril

23andMe CEO Set to Take On Sales Slump | DNA Testing: The Promise And The Peril

23andMe CEO

23andMe Files For Bankruptcy And CEO Anne Wojcicki Exits—Here's What We Know

23andMe Files For Bankruptcy And CEO Anne Wojcicki Exits—Here's What We Know

Genetic testing

How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong

How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong

DNA-testing

23andMe CEO Is Happy to be Done With SPAC Process

23andMe CEO Is Happy to be Done With SPAC Process

DEK: Data is critical as we continue to fight the pandemic - and genetic research

23andMe CEO on genetic testing relaunch, protecting privacy

23andMe CEO on genetic testing relaunch, protecting privacy

Two years ago, the

Inside 23andMe CEO Anne Wojcicki's vision for the company: It "will transform health care"

Inside 23andMe CEO Anne Wojcicki's vision for the company: It "will transform health care"

In an exclusive interview with "CBS Mornings" co-host Gayle King,

23andMe CEO Wojcicki: We are part of the problem

23andMe CEO Wojcicki: We are part of the problem

Anne Wojcicki,

23andMe CEO Wojcicki on Telehealth, Covid Research

23andMe CEO Wojcicki on Telehealth, Covid Research

23andMe CEO

23andMe Board Resigns: CEO's Bold Plan to Go Private Sparks Major Shakeup"

23andMe Board Resigns: CEO's Bold Plan to Go Private Sparks Major Shakeup"

In a shocking move, all independent directors at

23andMe CEO talks growth, drug development, and the future of health care

23andMe CEO talks growth, drug development, and the future of health care

healthcare #youtube #yahoofinance

23andMe files for Chapter 11 bankruptcy as co-founder and CEO resigns

23andMe files for Chapter 11 bankruptcy as co-founder and CEO resigns

23andMe

How 23andMe went from a $6 billion valuation to trading for pennies

How 23andMe went from a $6 billion valuation to trading for pennies

Cofounder and

23andMe CEO on company's future amid financial struggles, data security incident

23andMe CEO on company's future amid financial struggles, data security incident

23andMe CEO

‘Absolutely’ a future where everyone's DNA sequenced at birth: 23andMe CEO

‘Absolutely’ a future where everyone's DNA sequenced at birth: 23andMe CEO

23andMe

23andMe CEO Says 'We're a Complicated Story'

23andMe CEO Says 'We're a Complicated Story'

Anne Wojcicki,

23andMe CEO on public debut, future of genetic testing

23andMe CEO on public debut, future of genetic testing

23andMe

23andMe CEO on Staying Direct to Consumers

23andMe CEO on Staying Direct to Consumers

23andMe CEO

Sir Richard Branson discusses 23andMe SPAC Merger: 23andMe can lead to healthier lifestyles

Sir Richard Branson discusses 23andMe SPAC Merger: 23andMe can lead to healthier lifestyles

SirRichardBranson #

23andMe CEO on company's future amid data security incident, $30 million settlement

23andMe CEO on company's future amid data security incident, $30 million settlement

23andMe CEO